The circulating soluble RAGE (sRAGE), acting as decoy receptors, has been robustly demonstrated that low sRAGE levels are associated with advanced COPD and lung function decline, which may be counterintuitive with our results. This evidence concerns the gene AGER and chronic obstructive pulmonary disease.